Match tier Institution-verified
Presence Current · Arkansas
Last published 2026
Sources Institutional record
Refreshed 2026-10-05
Weida Tong profile photo

Weida Tong

Sourced from institutional research profiles (UAMS TRI or ARA).

◆ ARA Academy

Division Director

Also affiliated: United States Food and Drug Administration (2020–2021); Center for Devices and Radiological Health (2020); Fudan University (2020); Rhode Island Hospital (2021); Fudan University Shanghai Cancer Center (2020); Lifespan (2021); Sunnybrook Research Institute (2020); Odette Cancer Centre (2020)

4 h-index 7 pubs 705 cited

  • Humans
  • Animals
  • Gene Expression Profiling
  • Oligonucleotide Array Sequence Analysis
  • Algorithms
  • Chemical and Drug Induced Liver Injury
  • Drug-Related Side Effects and Adverse Reactions
  • United States
  • United States Food and Drug Administration
  • Reproducibility of Results
  • Artificial Intelligence
  • High-Throughput Nucleotide Sequencing
  • Rats
  • Computational Biology
  • Software

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Weida Tong leads a research group focused on bioinformatics and regulatory science. His work has investigated the reproducibility and accuracy of gene expression measurements, particularly concerning microarray and RNA sequencing technologies. This includes contributions to the MicroArray Quality Control (MAQC) project and the Sequencing Quality Control Consortium, which assessed inter- and intra-platform reproducibility and the impact of common practices on predictive model development.

Tong's research also encompasses the development and validation of predictive models, including the applicability domain of quantitative structure-activity relationships. He has published on the concordance between different gene expression measurement technologies and the transparency and reproducibility of artificial intelligence. His work has involved collaborations with researchers at the National Center for Toxicological Research, including Huixiao Hong, Joshua Xu, Leihong Wu, and Ting Li.

Metrics

  • h-index: 4
  • Publications: 7
  • Citations: 705

Positions

  • Division Director 1996–present
    National Center for Toxicological Research Division of Bioinformatics and Biostatistics Institutional directory

Selected Publications

  • Two decades of prescription opioid-related cardiovascular safety signals: a FAERS-based pharmacovigilance study using machine learning (2026)
    Frontiers in Drug Safety and Regulation DOI OpenAlex
  • Exploring Sex Differences in Cardiac ICU Admission and Length of Stay Using Multiple Correspondence Analysis (2026)
    Informatics DOI OpenAlex
  • Is regulatory science ready for artificial intelligence? (2025)
    npj Digital Medicine 42 citations DOI OpenAlex
  • AI-powered topic modeling: comparing LDA and BERTopic in analyzing opioid-related cardiovascular risks in women (2025)
    Experimental Biology and Medicine 58 citations DOI OpenAlex
  • Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research? (2025)
    2 citations DOI OpenAlex
  • Bridging organ transcriptomics for advancing multiple organ toxicity assessment with a generative AI approach (2024)
    14 citations DOI OpenAlex
  • Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs (2024)
    20 citations DOI OpenAlex
  • Progress in toxicogenomics to protect human health (2024)
    Nature Reviews Genetics 68 citations DOI OpenAlex
  • Text summarization with ChatGPT for drug labeling documents (2024)
    13 citations DOI OpenAlex
  • Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity (2024)
    19 citations DOI OpenAlex
  • Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project (2023)
    19 citations DOI OpenAlex
  • Measurement and Mitigation of Bias in Artificial Intelligence: A Narrative Literature Review for Regulatory Science (2023)
    Clinical Pharmacology & Therapeutics 35 citations DOI OpenAlex
  • Quartet DNA reference materials and datasets for comprehensively evaluating germline variant calling performance (2023)
    29 citations DOI OpenAlex
  • PLM-ARG: antibiotic resistance gene identification using a pretrained protein language model (2023)
    Bioinformatics 42 citations DOI OpenAlex
  • A generative adversarial network model alternative to animal studies for clinical pathology assessment (2023)
    Nature Communications 59 citations DOI OpenAlex

View all publications on OpenAlex →

ARA Academy 2016 ARA Fellow

Dr. Tong's work emphasizes developing bioinformatic tools and methodologies to support FDA research, regulatory science, and personalized medicine. His notable initiatives include the Microarray Quality Control (MAQC) consortium, the Liver Toxicity Knowledge Base (LTKB), in silico drug repositioning for rare disease treatment, and the ArrayTrack suite for pharmacogenomics review.

Policy Impact

Develops bioinformatic tools supporting FDA regulatory science and personalized medicine, anchoring critical federal research infrastructure in Arkansas.

Growth Areas

['Population Health Innovations & Clinical Research']

Collaboration Network

1037 Collaborators 409 Institutions 37 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics